Post Translational Medicines
Founded 2025
About Post Translational Medicines
Post Translational Medicines focuses on illuminating the dark proteome to develop next-gen therapeutics.
Company Facts
- Founded: 2025
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Total funding: $200.0K
- Funding stage: Seed
- Last round: Pre-Seed (Jun 2025)
- Website: https://ptmedicines.com/
Industries & Categories
Biotechnology, Life Science, Precision Medicine
Canonical: https://fsome.com/organization/post-translational-medicines-151852 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.